Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Experimentally Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder

NCT05340504 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT05340504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05340504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Experimentally Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder
Lead sponsor
Medical University of South Carolina
Phase
Phase 2
Overall status
Completed
Start date
May 13, 2022
Completion date
June 21, 2023
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, bipolar i disorder, bipolar ii disorder